We have been advocating that the diversity in genomics research is an issue since Mawi DNA’s inception in 2014. Interestingly, in late 2018 and now 2019 several publications came out to describe this issue in greater details. Unfortunately, such gap of genetic data hinders progress in understanding the global picture of human health and in particular personalized and precision medicine including the pharmacogenomics of how our bodies react to different drugs.
Spit and/or saliva collection might have been an acceptable alternative to getting gDNA from blood sample. But now it is becoming obvious that its use has many limitations:
iSWAB checks all of these requirements and more, making it a true universal sample collection technology!
Swabs are known to be a universal sample collection tool but lacked gDNA quantity and quality. Using it with iSWAB resolves this issue and thus making accessibility of samples from across the globe regardless of age, medical condition or level of education. iSWAB is bringing diversity back to genetic and multi-OMICS research.
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...READ MORE
High-Efficiency Collection and Release Of Oral DNA Samples...
"The full release capacity functionality allows for adequate sample capture needed for DNA sample collection and processing." Mawi DNA Technologies, a medical device company fo...READ MORE
Meet The Mawi DNA Team We’ll be exhibiting at Booth…...
JOIN US AT ASHG | Nov 1-5, 2023 | Walter E. Washington Convention Center| Washington, D.C Mawi DNA Technologies improves the biological sample collection process with innovative technologies. Our ...READ MORE